(NASDAQ: MASI) Masimo's forecast annual revenue growth rate of -1.54% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.54%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.99%.
Masimo's revenue in 2025 is $1,848,200,000.On average, 5 Wall Street analysts forecast MASI's revenue for 2025 to be $82,523,083,515, with the lowest MASI revenue forecast at $82,334,685,067, and the highest MASI revenue forecast at $82,699,747,804. On average, 5 Wall Street analysts forecast MASI's revenue for 2026 to be $88,839,755,355, with the lowest MASI revenue forecast at $88,196,332,282, and the highest MASI revenue forecast at $89,346,388,552.
In 2027, MASI is forecast to generate $96,006,719,153 in revenue, with the lowest revenue forecast at $95,557,344,308 and the highest revenue forecast at $96,625,913,360.